Novel fondaparinux protocol for anticoagulation therapy in adults with renal failure and suspected heparin-induced thrombocytopenia: a retrospective review of institutional protocol

Novel fondaparinux protocol for anticoagulation therapy in adults with renal failure and suspected heparin-induced thrombocytopenia: a retrospective review of institutional protocol

Plain Language Summary New Fondaparinux Protocol to Reduce the Risk of Blood Thickening and Blood Clots Formation in Adults with Kidney Disease and Heparin-induced Thrombocytopenia (drop in platelets after the use of heparin): A Test Study. Fondaparinux is a drug used to treat patients suffering fro...

Full description

Bibliographic Details
Main Authors: Dania Ghaziri, Hassan Dehaini, Mayyas Msheik, Marwan Bahmad, Maya Zorkot, George Abi Saad
Format: Article
Language:English
Published: BMC 2023-01-01
Series:BMC Pharmacology and Toxicology
Subjects:
Fondaparinux
Anticoagulation
Thrombocytopenia
Renal failure
dialysis
Online Access:https://doi.org/10.1186/s40360-023-00643-4

Internet

https://doi.org/10.1186/s40360-023-00643-4

Similar Items